Mozart Therapeutics
PrivateLast Round
Series A
Extension
Jun 7, 2023
Total Funding Raised
$80M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mozart Therapeutics is a biotechnology company that develops disease-modifying therapies for autoimmune and inflammatory diseases by targeting the CD8 T regulatory cell network.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mozart Therapeutics Comparables
Compare Mozart Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GentiBio | 87% | |
| Quell Therapeutics | 86% | |
| Avotres Inc. | 84% |
Mozart Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 7, 2023 | ||||
| Series A | Oct 26, 2021 |
Mozart Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series A, Series A Extension |
| ARCH Venture Partners | Series A Extension, Series A |
| ARCH Venture Partners | Series A Extension, Series A, Seed |
| AbbVie Ventures | Series A Extension |
| Alexandria Venture Investments | Series A, Series A Extension |
| Pfizer Ventures | Series A Extension |
| Sofinnova Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 61% MoM.
- Apr 23, 2026
Presented interim Phase Ib results at the Immunology of Diabetes Society Congress.
Mozart Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mozart Therapeutics's valuation, stock price, and market status.
Is Mozart Therapeutics a public or private company?
Mozart Therapeutics is a private company.
What is the current stock price of Mozart Therapeutics?
Mozart Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Mozart Therapeutics worth (valuation)?
Valuation information for Mozart Therapeutics is not publicly available.
Can I buy Mozart Therapeutics stock?
Mozart Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mozart Therapeutics's last funding round?
Mozart Therapeutics's most recent funding round was Series A Extension on June 7, 2023.
Who are the main investors in Mozart Therapeutics?
Key investors in Mozart Therapeutics include ARCH Venture Partners, Sofinnova Partners.
Will Mozart Therapeutics IPO soon?
No public IPO plans have been announced for Mozart Therapeutics.
How can I track Mozart Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mozart Therapeutics's secondary market activity and sign up for updates.